N. Nora Bennani
Sprint (United States)(US)Toyota Motor Corporation (Switzerland)(CH)Mayo Clinic(US)Rochester Institute of Technology(US)WinnMed(US)Cancer Clinic(US)Mayo Clinic in Arizona(US)Centre Hospitalier Ibn Sina(MA)Mayo Clinic in Florida(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Histiocytic Disorders and Treatments, Cutaneous lymphoproliferative disorders research, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium(2020)762 cited
- → Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease(2019)207 cited
- → The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease(2019)186 cited
- → Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms(2017)148 cited
- → DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study(2017)135 cited
- → Genetic subtyping of breast implant–associated anaplastic large cell lymphoma